According to a recent article by Forbes, in which it points to “official documents procured exclusively,” Bulgaria has issued an authorization to a company permitting the sale of hemp-derived cannabidiol in open markets.
The license was issued to Kannaway, a producer of products containing CBD. The company is also a subsidiary of Medical Marijuana Inc., a publicly traded company. The article adds that the certificate allows for exports and also states that the companies are certified to “comply fully with relevant requirements of the Law on Foodstuffs of the Republic of Bulgaria and of regulation (EC) No 852/2004 of European Parliament and the Council on the hygiene of foodstuffs.”
Medical Marijuana, Inc. issued a press release announcing the license. Therein, Kannaway CEO Blake Schroeder stated,
“As the EU continues to navigate its stance on CBD, we are proud to continue paving the way for the acceptance of CBD in Bulgaria just as we have in many other countries around the world. With this authorization, we hope that we can establish our company as pioneers in Bulgaria's CBD industry and leaders in CBD education throughout Europe.”
The company’s Vice President of International, Alex Grapov, also discussed the license. He said,
“As a company of firsts, we look forward to trailblazing the international CBD market as advocates of this supplement's potential benefits. We have met with all of the appropriate regulatory bodies to ensure that our operations are within the bounds of the law creating a stable opportunity for our customers and Brand Ambassadors.”
Perhaps Bulgaria’s issuance of a permit permitting the sale of CBD will set precedent for other countries in the European Union.